CORRESP Filing
CRESCENT BIOPHARMA, INC.
Date: May 13, 2025 · CIK: 0001253689 · Accession: 0001104659-25-047721
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-285035
Letter
VIA EDGAR Division of Corporation Finance Office of Life Sciences Securities and Exchange Commission Attention: Jessica Dickerson Registration Statement on Form S-4, as amended Filed on February 18, 2025, as amended on April 4, 2025, April 29, 2025 and May 12, 2025 File No. 333-285035 (as amended, the “Registration Statement”) Request for Acceleration
Dear Ms. Dickerson,
Pursuant to Rule 461 of the Rules and Regulations of the Securities and Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended, GlycoMimetics, Inc. (the “Company”) hereby respectfully requests acceleration of the effective date of the Registration Statement, so that it may become effective at 4:01 p.m., Eastern Time, on May 14, 2025, or as soon thereafter as practicable. The Company hereby authorizes each of Asher M. Rubin, John H. Butler, and Kostian Ciko of Sidley Austin LLP, counsel to the Company, to make such request on its behalf.
Once the Registration Statement is effective, please orally confirm the event with the Company’s counsel, Sidley Austin LLP by calling Kostian Ciko at (212) 839-5450. The Company also respectfully requests that a copy of the written order from the Commission verifying the effective time and date of the Registration Statement be sent to kciko@sidley.com.
Should any member of the staff of the Commission have any questions or comments with respect to this request, please contact our counsel, Sidley Austin LLP, by calling Kostian Ciko at (212) 839-5450.
Very truly yours,
GLYCOMIMETICS, INC.
Show Raw Text
CORRESP
1
filename1.htm
GlycoMimetics, Inc.
P.O. Box 65
Monrovia, Maryland 21770
(240) 243-1201
May 13, 2025
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
Securities and Exchange Commission
Washington, D.C. 20549
Attention: Jessica Dickerson
Re:
GlycoMimetics, Inc.
Registration Statement on Form S-4, as amended
Filed on February 18, 2025, as amended on April
4, 2025, April 29, 2025 and May 12, 2025
File No. 333-285035 (as amended, the “Registration
Statement”)
Request for Acceleration
Dear Ms. Dickerson,
Pursuant
to Rule 461 of the Rules and Regulations of the Securities and Exchange Commission (the “Commission”) under
the Securities Act of 1933, as amended, GlycoMimetics, Inc. (the “Company”) hereby respectfully requests acceleration
of the effective date of the Registration Statement, so that it may become effective at 4:01 p.m., Eastern Time, on May 14, 2025, or as
soon thereafter as practicable. The Company hereby authorizes each of Asher M. Rubin, John H. Butler, and Kostian Ciko of Sidley
Austin LLP, counsel to the Company, to make such request on its behalf.
Once
the Registration Statement is effective, please orally confirm the event with the Company’s counsel, Sidley Austin LLP by
calling Kostian Ciko at (212) 839-5450. The Company also respectfully requests that a copy of the written order from the Commission verifying
the effective time and date of the Registration Statement be sent to kciko@sidley.com.
Should any member of the staff
of the Commission have any questions or comments with respect to this request, please contact our counsel, Sidley Austin LLP, by calling
Kostian Ciko at (212) 839-5450.
Very truly yours,
GLYCOMIMETICS, INC.
By:
/s/ Brian Hahn
Brian Hahn
Principal Executive and Financial Officer
cc:
Asher M. Rubin, Esq., Sidley Austin LLP
John H. Butler, Esq., Sidley Austin LLP
Kostian Ciko, Esq., Sidley Austin LLP
Ryan A. Murr, Esq., Gibson, Dunn & Crutcher LLP
Branden C. Berns, Esq., Gibson, Dunn & Crutcher LLP